tiprankstipranks
Tonix Pharma (TNXP)
NASDAQ:TNXP
US Market

Tonix Pharma (TNXP) Income Statement

Compare
4,304 Followers

Tonix Pharma Income Statement

Last quarter (Q3 2024), Tonix Pharma's total revenue was $2.82M, a decrease of -29.26% from the same quarter last year. In Q3, Tonix Pharma's net income was $-14.21M. See Tonix Pharma’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 7.77M$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 3.03M$ -112.09M$ -92.31M$ -50.51M$ -28.83M
Operating Expenses
$ 121.41M$ 112.09M$ 92.31M$ 50.51M$ 28.83M
Depreciation and Amortization
$ 4.29M$ 1.25M$ 50.00K$ 27.00K$ 26.00K
EBITDA
$ -114.09M$ -110.84M$ -92.26M$ -50.48M$ -28.80M
Operating Income
$ -118.38M$ -112.09M$ -92.31M$ -50.51M$ -28.83M
Other Income/Expenses
$ 1.72M$ 1.87M$ 25.00K$ 48.00K$ 210.00K
Pretax Income
$ -116.66M$ -110.22M$ -92.29M$ -50.46M$ -28.62M
Net Income
$ -116.66M$ -116.88M$ -92.29M$ -52.17M$ -31.09M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -219.09$ -640.26$ -1.62K$ -3.53K$ 0.00
Diluted EPS
$ -219.09$ -640.26$ -1.62K$ -3.53K$ 0.00
Weighted Average Shares Outstanding
532.48K 182.54K 56.94K 14.78K 0.00
Weighted Average Shares Outstanding (Diluted)
532.48K 182.54K 56.94K 14.78K 0.00
Currency in USD

Tonix Pharma Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis